Trials / Conditions / Scheie Syndrome
Scheie Syndrome
6 registered clinical trials studyying Scheie Syndrome.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I NCT00852358 | Patricia I. Dickson, M.D. | N/A |
| Terminated | Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I NCT00786968 | Patricia I. Dickson, M.D. | Phase 1 |
| Completed | Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease NCT00258011 | Genzyme, a Sanofi Company | Phase 3 |
| Completed | A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease NCT00144781 | Genzyme, a Sanofi Company | Phase 4 |
| Completed | A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Y NCT00146757 | Genzyme, a Sanofi Company | Phase 2 |
| Completed | Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS NCT00146770 | Genzyme, a Sanofi Company | Phase 3 |